Recent Blog Articles

Diseases & Conditions

Biologic therapy doesn't raise cancer risk in people with rheumatoid arthritis

Updated: November 01, 2012

Despite theoretical reasons to worry that biologic response modifiers may raise cancer risk, it appears they don’t significantly raise the risk of malignancy. The drugs can dramatically improve inflammation in people with rheumatoid arthritis.

To continue reading this article, you must log in.

Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.

  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »

I'd like to receive access to Harvard Health Online for only $4.99 a month.

Sign Me Up

Already a member? Login ».


As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.